发明名称 |
ANTIBODY FORMULATION |
摘要 |
Anti-BAFFR antibodies are formulated as liquid formulation comprising a high concentration of the antibody active ingredient for delivery to a patient without high levels of antibody aggregation. The aqueous pharmaceutical composition may include one or more sugars, a buffering agent, a surfactant, and/or a free amino acid. |
申请公布号 |
WO2013186700(A1) |
申请公布日期 |
2013.12.19 |
申请号 |
WO2013IB54777 |
申请日期 |
2013.06.11 |
申请人 |
NOVARTIS AG;COSENZA, MARTA;STARK, CHRISTOPH |
发明人 |
COSENZA, MARTA;STARK, CHRISTOPH |
分类号 |
A61K39/395;A61K9/00;A61K47/18;A61K47/26;C07K16/28 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|